Amrutanjan Health Care Limited (BOM:590006)

Amrutanjan Health Care Income Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Operating Revenue	4,699	4,518	4,212	3,796	4,058	3,328
Other Revenue	1.47	1.47	1.41	1.23	1.06	1.69
Revenue	4,701	4,520	4,214	3,798	4,059	3,330
Revenue Growth (YoY)	7.36%	7.26%	10.96%	-6.45%	21.90%	27.23%
Cost of Revenue	2,376	2,289	2,170	1,874	1,838	1,432
Gross Profit	2,325	2,230	2,043	1,924	2,221	1,899
Selling, General & Admin	607.44	597.16	484.02	492.2	484.84	420.53
Other Operating Expenses	1,041	1,035	1,026	960	879.76	647.2
Operating Expenses	1,713	1,698	1,571	1,505	1,423	1,181
Operating Income	612.34	532.59	472.47	418.55	798.41	717.93
Interest Expense	-2	-2.19	-1.57	-0.77	-4.85	-5
Interest & Investment Income	160.47	160.47	148.05	117.83	111.7	93.88
Currency Exchange Gain (Loss)	0.26	0.26	0.62	2.38	1.25	0.59
Other Non Operating Income (Expenses)	2.44	0.19	0.69	0.24	0.83	0.42
EBT Excluding Unusual Items	773.51	691.32	620.26	538.23	907.34	807.82
Gain (Loss) on Sale of Investments	0.02	0.02	-1.26	-2.05	-1.57	-3.67
Gain (Loss) on Sale of Assets	-	-	1.57	0.27	-	0.89
Asset Writedown	-	-	-1.11	-	-	-
Pretax Income	773.53	691.34	619.46	536.45	905.77	819.05
Income Tax Expense	206.56	182.99	169.73	138.11	233.88	207.14
Earnings From Continuing Operations	566.96	508.35	449.73	398.35	671.89	611.9
Net Income	566.96	508.35	449.73	398.35	671.89	611.9
Net Income to Common	566.96	508.35	449.73	398.35	671.89	611.9
Net Income Growth	19.31%	13.04%	12.90%	-40.71%	9.80%	143.95%
Shares Outstanding (Basic)	29	29	29	29	29	29
Shares Outstanding (Diluted)	29	29	29	29	29	29
Shares Change (YoY)	-0.02%	-0.38%	-0.71%	-0.03%	0.00%	0.02%
EPS (Basic)	19.60	17.58	15.50	13.65	23.00	20.94
EPS (Diluted)	19.60	17.58	15.50	13.63	22.98	20.93
EPS Growth	19.32%	13.44%	13.70%	-40.69%	9.79%	143.94%
Free Cash Flow	-51	153.46	211.93	112.54	287.32	889.09
Free Cash Flow Per Share	-1.76	5.31	7.30	3.85	9.83	30.41
Dividend Per Share	4.600	4.600	4.600	4.600	4.600	4.200
Dividend Growth	-	-	-	-	9.52%	281.82%
Gross Margin	49.46%	49.35%	48.49%	50.65%	54.72%	57.01%
Operating Margin	13.03%	11.78%	11.21%	11.02%	19.67%	21.56%
Profit Margin	12.06%	11.25%	10.67%	10.49%	16.55%	18.38%
Free Cash Flow Margin	-1.08%	3.40%	5.03%	2.96%	7.08%	26.70%
EBITDA	662.93	584.69	520.33	458.66	830.49	747.3
EBITDA Margin	14.10%	12.94%	12.35%	12.08%	20.46%	22.44%
D&A For EBITDA	50.59	52.1	47.86	40.11	32.09	29.37
EBIT	612.34	532.59	472.47	418.55	798.41	717.93
EBIT Margin	13.03%	11.78%	11.21%	11.02%	19.67%	21.56%
Effective Tax Rate	26.70%	26.47%	27.40%	25.74%	25.82%	25.29%
Revenue as Reported	4,878	4,695	4,376	3,942	4,212	3,442

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.